Periselneris, J., Nwankwo, L., Schelenz, S., Shah, A., & Armstrong-James, D. (2019). Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy (JAC), 74(6), 1701. https://doi.org/10.1093/jac/dkz075
Chicago Style (17th ed.) CitationPeriselneris, J., L. Nwankwo, S. Schelenz, A. Shah, and D. Armstrong-James. "Posaconazole for the Treatment of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis." Journal of Antimicrobial Chemotherapy (JAC) 74, no. 6 (2019): 1701. https://doi.org/10.1093/jac/dkz075.
MLA (9th ed.) CitationPeriselneris, J., et al. "Posaconazole for the Treatment of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis." Journal of Antimicrobial Chemotherapy (JAC), vol. 74, no. 6, 2019, p. 1701, https://doi.org/10.1093/jac/dkz075.